LATONYA BROWN: Open Payments
NPI 1023064920 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,902 in 100 payments from 27 companies in 2025. Trend: 2023 $1,702 · 2024 $1,593 · 2025 $1,902
Food & beverage: $1,902
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $409 |
| Novo Nordisk Inc | 4 | $175 |
| PFIZER INC. | 10 | $160 |
| Kowa Pharmaceuticals America, Inc. | 13 | $157 |
| Amgen Inc. | 10 | $150 |
| ABBVIE INC. | 8 | $127 |
| Ardelyx, Inc. | 6 | $123 |
| Abbott Laboratories | 6 | $111 |
| Sumitomo Pharma America, Inc. | 2 | $39 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
Products named: BREZTRI, ZORYVE, FARXIGA, Ozempic, OTEZLA, IBSRELA, FREESTYLE LIBRE 3, NURTEC ODT.
Industry payments across SC — which companies pay providers there.
